Clinical Trials on Recurrent Lung Carcinoma in Italy

Total 3802 results

Beatrice Aramini

Completed

The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung

Lung Cancer, Nonsmall Cell | Relapse/Recurrence | CSC

Italy
Centre for Endocrinology and Reproductive Medicine...

Recruiting

Use of GM-CSF Treatment in Recurrent Implantation Failure

Women With Recurrent Implantation Failure in IVF

Italy
Azienda Ospedaliero, Universitaria Ospedali Riuniti

Recruiting

Therapy Management in Patients Treated With Anakinra Due to Recurrent Pericarditis

Recurrent Pericarditis

Italy
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)

Stage IV or Recurrent Non-Small Cell Lung Cancer

United States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
Nektar Therapeutics
Merck Sharp & Dohme LLC; SFJ Pharmaceuticals, Inc.

Terminated

BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)

Recurrent Head and Neck Cancer | Metastatic Head and Neck Cancer

United States, Austria, Greece, Italy
Massimo Imazio

Completed

AnakInRa for Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP) (AIR TRIP)

Idiopathic Recurrent Pericarditis

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer. (MITO29)

Recurrent, Platinum-resistant Ovarian Cancer

Italy
Bristol-Myers Squibb

Active, not recruiting

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung Cancer

Australia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Spain, Switzerland, United Kingdom
University of Bologna

Completed

Intraoperative Neuromonitoring of the Recurrent Laryngeal Nerve Versus Neurostimulation

Thyroidectomy

Italy
IRCCS Policlinico S. Matteo

Completed

D Mannose in Recurrent Urinary Tract Infections

Recurrent Urinary Tract Infection

Italy
Corcept Therapeutics

Active, not recruiting

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian Cancer

United States, Belgium, Canada, Italy, Spain
Study Group for Urogenital Diseases, Italy

Unknown

Retrospective Analysis of Ialuril vs. Standard of Care in Recurrent Urinary Tract Infections (RAISC-RUTI)

Recurrent Urinary Tract Infections

Italy
IRCCS Policlinico S. Matteo

Completed

D Mannose for Prevention and Treatment of RUTIs (mannoseRUTIs)

Antibiotic Resistance | Antibiotic Prophylaxis | Recurrent Urinary Tract Infections

Italy
National Cancer Institute, Naples

Recruiting

Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study (MITO 31)

BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Italy
Istituto Clinico Humanitas

Unknown

Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or Immunotherapy (MITOMARKER-MIM)

Bladder Cancer

Italy
Grupo Español de Investigación en Cáncer de Ovario
GlaxoSmithKline; Hoffmann-La Roche; Apices Soluciones S.L.; AGO Study Group; ARCAGY... and other collaborators

Active, not recruiting

Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)

Recurrent Ovarian Carcinoma

France, Spain, Belgium, Italy, Germany
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation (TeRes)

Small Cell Lung Cancer Recurrent

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

Effect of Hyaluronic Acid Oral Supplementation on Sexual and Urinary Symptoms of Women With Recurrent Urinary Tract Infections (JalUrol)

Urinary Tract Infections, Recurrent

Italy
European Hepatocellular Cancer Liver Transplant...

Completed

Deep Learning Model for the Prediction of Post-LT HCC Recurrence (TRAIN-AI)

Liver Cancer | Liver Transplant Disorder | Recurrent Cancer

Italy
Istituto Clinico Humanitas

Completed

Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma

Recurrent High Grade Glioma

Italy
CM&D Pharma Limited

Completed

Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence (CRC)

Adenocarcinoma of Colon Recurrent

Italy
Istituto Clinico Humanitas

Recruiting

Feasibility of Radioisotope-guided Excision of Mediastinal Lymph Nodes in Patients With Non-small Cells Lung Carcinoma (SLN_NSCLC)

Lung Cancer

Italy
Catholic University of the Sacred Heart

Unknown

Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer (MITOBEVAEND2)

Stage III-IV or Recurrent Endometrial Cancer

Italy
Radiotherapy Oncology Centre "Santa Maria" Hospital
Paola Anselmo,MD; Michelina Casale,PhD; Ernesto Maranzano,MD; Fabio Trippa,MD

Completed

Stereotactic Ablative Radiotherapy in Locally Advanced Non Small Cell Lung Cancer (START-NEW-ERA)

Locally Advanced Lung Non-Small Cell Carcinoma

Italy
UroGen Pharma Ltd.

Recruiting

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer | Non-muscle Invasive Bladder Cancer | Urothelial Carcinoma Bladder | NMIBC | Urothelial Carcinoma Recurrent | Carcinoma in Situ of Bladder

United States, Italy, Spain
Istituto Oncologico Veneto IRCCS

Terminated

TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES) (TIMES)

Carcinoma, Small Cell

Italy
ETOP IBCSG Partners Foundation
Hoffmann-La Roche

Terminated

ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer (ALERT-lung)

Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Recurrent

Ireland, Spain, Belgium, Italy, Netherlands, Switzerland
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Politecnico di Milano

Recruiting

Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS) (LM)

Locally Advanced Lung Non-Small Cell Carcinoma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma. (HBO-RT)

High Grade Glioma | Malignant Glioma | Recurrent Glioma

Italy
Pierre Fabre Medicament

Completed

CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study

Recurrent Upper-Respiratory Tract Infections

Italy, Poland, Romania, Russian Federation, Lithuania
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

From Benchmark to Surgical Activity: the Role of Endobronchial Fiducial Markers for Ground Glass Lung Nodules Resection. (Vortex_US)

Lung Cancer | Lung Non-Small Cell Carcinoma | Lung; Node

Italy
European Organisation for Research and Treatment...

Unknown

Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo (EVIDENCE)

Non-small Cell Lung Carcinoma

Italy, United Kingdom
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Partial Breast Re-irradiation in Women in Women With Locally Recurrent Breast Cancer Previously Treated With Conservative Surgery and Whole Breast Irradiation (PBReI)

Breast Cancer | Recurrent

Italy
IRCCS Policlinico S. Matteo
Azienda Ospedaliera Universitaria Integrata Verona; San Luigi Gonzaga Hospital and other collaborators

Recruiting

Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer (MURAL)

Lung Cancer, Nonsmall Cell

Italy
National Cancer Institute, Naples
AstraZeneca; University of Campania "Luigi Vanvitelli"

Recruiting

A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5) (MILES-5)

Carcinoma, Non-Small-Cell Lung

Italy
Sanofi

Completed

ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Italy
Azienda Ospedaliera Universitaria Integrata Verona
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione IRCCS... and other collaborators

Unknown

OMEGA, Local Ablative Therapy in Oligometastatic NSCLC (OMEGA)

Carcinoma, Non-Small-Cell Lung

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer (PICASSO)

Small Cell Lung Cancer

Italy
Campus Bio-Medico University

Unknown

Adaptive Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (LARTIA Trial) (LARTIA)

Non-Small Cell Lung Cancer

Italy
University of Bologna
Azienda Ospedaliera Città della Salute e della Scienza di Torino; IRCCS Azienda... and other collaborators

Not yet recruiting

HOPE to Reduce Tumour Recurrence After LT In Patients With HCC (POTERE)

Liver Transplantation | Hepatocellular Carcinoma | Liver Cancer | Tumor Recurrence | Ex-vivo Hypothermic Perfusion

Italy
Istituto Nazionale per lo Studio e la Cura dei...

Unknown

Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Lung Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...
University of Milan; IFOM, The FIRC Institute of Molecular Oncology

Not yet recruiting

FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction (FASTIMMUNE)

Small Cell Lung Carcinoma

Italy
European Institute of Oncology

Completed

Radiomics and Radiogenomics of Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

Italy
Sanofi

Completed

Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.

Non-small Cell Lung Cancer

Italy
University Hospital Plymouth NHS Trust
University of Plymouth

Completed

Recurrence After Whipple's (RAW) Study

Pancreatic Cancer | Surgery | Bile Duct Cancer | Pancreatic Ductal Adenocarcinoma | Survivorship | Cholangiocarcinoma, Extrahepatic | Cancer Recurrence | Recurrent Cancer | Pancreatic Ductal Carcinoma | Cholangiocarcinoma of the Extrahepatic Bile Duct | Ampullary Cancer | Cholangiocarcinoma Resectable | Cancer... and other conditions

Spain, United Kingdom, Australia, Austria, Italy, Mexico, Sudan, Pakistan
University of Milano Bicocca

Recruiting

Heterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer (TUM-DC)

Non-small Cell Lung Cancer

Italy
IRCCS Azienda Ospedaliera Universitaria San Martino...

Unknown

GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial

Non Small Cell Lung Cancer

Italy
IRCCS Azienda Ospedaliera Universitaria San Martino...
Azienda Ospedaliera Universitaria Integrata Verona; Azienda Ospedaliera San... and other collaborators

Unknown

Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease (CONTEST)

Non Small Cell Lung Cancer

Italy
Eli Lilly and Company

Completed

Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Italy
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma (NGR007)

Small Cell Lung Cancer

Italy

Clinical Trials on Recurrent Lung Carcinoma in Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations